331 related articles for article (PubMed ID: 37686309)
1. A Deep View of the Biological Property of Interleukin-33 and Its Dysfunction in the Gut.
Wang Y; He C; Xin S; Liu X; Zhang S; Qiao B; Shang H; Gao L; Xu J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686309
[TBL] [Abstract][Full Text] [Related]
2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
3. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
4. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
Dharmani P; Chadee K
Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immune systems of pediatric inflammatory bowel disease: A review.
Kudo T; Shimizu T
Pediatr Int; 2023; 65(1):e15511. PubMed ID: 36799518
[TBL] [Abstract][Full Text] [Related]
6. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms Underlying IL-33-Mediated Inflammation in Inflammatory Bowel Disease.
Aggeletopoulou I; Tsounis EP; Triantos C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614065
[TBL] [Abstract][Full Text] [Related]
8. Elevated IL-6 and IL-22 in Early Pregnancy Are Associated with Worse Disease Course in Women with Inflammatory Bowel Disease.
Wu RY; Xiao K; Hotte N; Tandon P; Elloumi Y; Ambrosio L; Dunsmore G; Elahi S; Kroeker KI; Dieleman LA; Madsen KL; Huang V
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142193
[TBL] [Abstract][Full Text] [Related]
9. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
[TBL] [Abstract][Full Text] [Related]
10. IL-23 in inflammatory bowel diseases and colon cancer.
Neurath MF
Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
[TBL] [Abstract][Full Text] [Related]
11. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
12. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
13. IBD immunopathogenesis: A comprehensive review of inflammatory molecules.
Park JH; Peyrin-Biroulet L; Eisenhut M; Shin JI
Autoimmun Rev; 2017 Apr; 16(4):416-426. PubMed ID: 28212924
[TBL] [Abstract][Full Text] [Related]
14. TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease.
Furfaro F; Alfarone L; Gilardi D; Correale C; Allocca M; Fiorino G; Argollo M; Zilli A; Zacharopoulou E; Loy L; Roda G; Danese S
Curr Drug Targets; 2021; 22(7):760-769. PubMed ID: 33475057
[TBL] [Abstract][Full Text] [Related]
15. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
Alimohammadi N; Koosha F; Rafeian-Kopaei M
Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220
[TBL] [Abstract][Full Text] [Related]
16. Study of tumor necrosis factor receptor in the inflammatory bowel disease.
Souza RF; Caetano MAF; Magalhães HIR; Castelucci P
World J Gastroenterol; 2023 May; 29(18):2733-2746. PubMed ID: 37274062
[TBL] [Abstract][Full Text] [Related]
17. Patterns of mucosal inflammation in pediatric inflammatory bowel disease: striking overexpression of IL-17A in children with ulcerative colitis.
Busch MA; Gröndahl B; Knoll RL; Pretsch L; Doganci A; Hoffmann I; Kullmer U; Bähner V; Zepp F; Meyer CU; Gehring S
Pediatr Res; 2020 Apr; 87(5):839-846. PubMed ID: 31261370
[TBL] [Abstract][Full Text] [Related]
18. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
19. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
20. Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease.
Bai X; Liu W; Chen H; Zuo T; Wu X
Front Immunol; 2022; 13():861790. PubMed ID: 35371090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
